Page last updated: 2024-11-04

sulfasalazine and Cataract

sulfasalazine has been researched along with Cataract in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, SJ1
Bae, S1
Seomun, Y1
Son, MJ1
Joo, CK1

Other Studies

1 other study available for sulfasalazine and Cataract

ArticleYear
The role of nuclear factor kappa B in lens epithelial cell proliferation using a capsular bag model.
    Ophthalmic research, 2008, Volume: 40, Issue:5

    Topics: Animals; Blotting, Western; Cataract; Cell Movement; Cell Proliferation; Cells, Cultured; Epithelial

2008